Skip to main content
The Journal of Infectious Diseases logoLink to The Journal of Infectious Diseases
. 2020 May 18;222(2):341–342. doi: 10.1093/infdis/jiaa172

Corrigendum to: Dengue Endemicity, Force of Infection and Variation in Transmission Intensity From 13 Endemic Countries

Joshua Nealon 1, Alain Bouckenooghe 2, Margarita Cortes 3, Laurent Coudeville 1, Carina Frago 2, Denis Macina 1, Clarence C Tam 4,5,6
PMCID: PMC7323489  PMID: 32421172

In “Dengue Endemicity, Force of Infection and Variation in Transmission Intensity From 13 Endemic Countries” by Nealon et al [J Infect Dis 2020; jiaa132], the advance online publication contained three errors in Table 3, introduced through a Stata coding error. The legend for Figure 2 also incorrectly described the confidence intervals in the figure. The correct table and figures are provided below, and are correct in the printed version.

Table 3.

Ages at Which 50% and 80% of Children Become Dengue Seropositive, Per Country, Using Constant or Age-Varying Models

Median Age at Seroconversion, y (95% CI) 80th Percentile Age at Seroconversion, y (95% CI)
Country Constant Model Age-Varying Model Constant Model Age-Varying Model
India 5.8 (5.5–6.1) 6.5 (6.0–6.9) 13.5 (12.8–14.3) 11.1 (8.8–17.4)
Indonesia 4.7 (4.5–4.9) 4.6 (4.4–4.8) 11.0 (10.5–11.5) 10.6 (10.1–11.2)
Malaysia 8.1 (7.1–9.2) 9.2 (5.9–>18) 18.8 (16.6–21.3) >18
Philippines 2.9 (2.6–3.2) 1.6 (1.4–3.1) 6.7 (6.1–7.4) 8.7 (6.6–12.2)
Singapore >18 >18 >18 >18
Thailand 4.7 (4.2–5.2) 4.2 (3.7–4.9) 10.9 (9.8–12.0) 12.7 (0.0–40.2)
Vietnam 6.1 (5.5–6.8) 5.1 (4.3–6.5) 14.1 (12.7–15.7) >18
Brazil 6.5 (5.8–7.3) 7.5 (6.4–9.1) 15.1 (13.4–17.0) 13.3 (11.9–17.4)
Colombia 3.8 (3.5–4.1) 3.7 (3.4–4.1) 8.8 (8.1–9.5) 8.6 (7.9–9.4)
Honduras 4.0 (3.5–4.5) 3.9 (3.3–4.7) 9.2 (8.2–10.3) 9.0 (7.7–10.9)
Mexico 9.8 (8.8–10.9) 9.0 (8.0–10.4) >18 >18
Peru 7.5 (6.5–8.7) 10.6 (6.5–28.8) 17.4 (15.1–20.2) >18
Puerto Rico 8.2 (7.0–9.6) 7.9 (6.6–9.8) >18 >18

Best-fitting models are highlighted in bold.

Figure 2.

Figure 2.

Observed seroprevalence by age (circles) and 95% confidence interval (CI), adjusted for clustering (spikes) and estimate seroprevalence assuming constant force of infection (FOI) (solid line) and 95% CIs (shaded area). Dotted lines correspond to estimated seroprevalence under an assumption of age-varying FOI.

The authors regret the errors.


Articles from The Journal of Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES